Your browser doesn't support javascript.
loading
Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.
Seitz-Holland, Johanna; Cetin-Karayumak, Suheyla; Wojcik, Joanne D; Lyall, Amanda; Levitt, James; Shenton, Martha E; Pasternak, Ofer; Westin, Carl-Fredrik; Baxi, Madhura; Kelly, Sinead; Mesholam-Gately, Raquelle; Vangel, Mark; Pearlson, Godfrey; Tamminga, Carol A; Sweeney, John A; Clementz, Brett A; Schretlen, David; Viher, Petra Verena; Stegmayer, Katharina; Walther, Sebastian; Lee, Jungsun; Crow, Tim; James, Anthony; Voineskos, Aristotle; Buchanan, Robert W; Szeszko, Philip R; Malhotra, Anil K; Rathi, Yogesh; Keshavan, Matcheri; Kubicki, Marek.
Affiliation
  • Seitz-Holland J; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jseitz@bwh.harvard.edu.
  • Cetin-Karayumak S; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Wojcik JD; Department of Psychiatry, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA, USA.
  • Lyall A; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Levitt J; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Shenton ME; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pasternak O; VA Boston Healthcare System, Brockton, MA, USA.
  • Westin CF; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Baxi M; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Kelly S; VA Boston Healthcare System, Brockton, MA, USA.
  • Mesholam-Gately R; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Vangel M; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pearlson G; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Tamminga CA; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Sweeney JA; Graduate Program of Neuroscience, Boston University, Boston, MA, USA.
  • Clementz BA; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Schretlen D; Department of Psychiatry, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA, USA.
  • Viher PV; Department of Psychiatry, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA, USA.
  • Stegmayer K; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Walther S; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Lee J; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
  • Crow T; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.
  • James A; Department of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, GA, USA.
  • Voineskos A; Department of Psychiatry and Behavioral Sciences, Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Buchanan RW; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Szeszko PR; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Malhotra AK; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Rathi Y; Department of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Keshavan M; Department of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.
  • Kubicki M; Department of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.
Mol Psychiatry ; 26(9): 5357-5370, 2021 09.
Article in En | MEDLINE | ID: mdl-33483689
ABSTRACT
White matter (WM) abnormalities are repeatedly demonstrated across the schizophrenia time-course. However, our understanding of how demographic and clinical variables interact, influence, or are dependent on WM pathologies is limited. The most well-known barriers to progress are heterogeneous findings due to small sample sizes and the confounding influence of age on WM. The present study leverages access to the harmonized diffusion magnetic-resonance-imaging data and standardized clinical data from 13 international sites (597 schizophrenia patients (SCZ)). Fractional anisotropy (FA) values for all major WM structures in patients were predicted based on FA models estimated from a healthy population (n = 492). We utilized the deviations between predicted and real FA values to answer three essential questions. (1) "Which clinical variables explain WM abnormalities?". (2) "Does the degree of WM abnormalities predict symptom severity?". (3) "Does sex influence any of those relationships?". Regression and mediator analyses revealed that a longer duration-of-illness is associated with more severe WM abnormalities in several tracts. In addition, they demonstrated that a higher antipsychotic medication dose is related to more severe corpus callosum abnormalities. A structural equation model revealed that patients with more WM abnormalities display higher symptom severity. Last, the results exhibited sex-specificity. Males showed a stronger association between duration-of-illness and WM abnormalities. Females presented a stronger association between WM abnormalities and symptom severity, with IQ impacting this relationship. Our findings provide clear evidence for the interaction of demographic, clinical, and behavioral variables with WM pathology in SCZ. Our results also point to the need for longitudinal studies, directly investigating the casualty and sex-specificity of these relationships, as well as the impact of cognitive resiliency on structure-function relationships.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / White Matter Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / White Matter Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Year: 2021 Type: Article